Press Releases

Find a Press Release

Filter by title, date, or content:

Norgen Biotek Corp. Achieves Accreditation to ISO 15189:2007 for Molecular Diagnostic Testing and Clinical Trials

October 5, 2011

/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein preservation and purification from all type of specimens for research and molecular diagnostic applications, today announced successful accreditation to ISO 15189:2007 by the Standards Council of Canada (SCC). This ISO accreditation emphasizes our commitment to quality in our laboratory and R&D services.

Read More

Norgen Biotek Corp (NBC) Launches 6 Novel Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma, Serum and Urine

June 4, 2014

/CNW/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 6 novel kits for the fast and simple isolation of NA from blood, plasma/serum and urine, including cell-free-circulating (cfc)RNA, cfcDNA and sequential cfcDNA and cfcRNA.

Read More

Norgen Biotek Corp. Achieves ISO 13485:2003 and ISO 9001:2008 Certification

November 3, 2009

/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein purification, today announced successful certification to ISO 13485:2003 and ISO 9001:2008. ISO 13485 and ISO 9001 are world-recognized quality management system standards, with ISO 13485 specifically pertaining to the requirements for a comprehensive management system for the design and manufacture of medical devices.

Read More